litlas
Log inCreate account

Nadeem Riaz

Active 2009–2026

135
Papers
26,550
Citations
71
h-index
125
i10-index

Citations

Citations per year for Nadeem Riaz1928: 1 citations1976: 1 citations1977: 1 citations1995: 3 citations1997: 1 citations2000: 1 citations2001: 1 citations2007: 1 citations2009: 3 citations2010: 1 citations2011: 3 citations2012: 5 citations2013: 3 citations2014: 8 citations2015: 12 citations2016: 36 citations2017: 103 citations2018: 288 citations2019: 1,144 citations2020: 1,755 citations2021: 1,952 citations2022: 1,700 citations2023: 1,222 citations2024: 1,836 citations2025: 883 citations2026: 25 citations1929–1975: no citations, so these years are not shown1978–1994: no citations, so these years are not shown1996: no citations, so this year is not shown1998–1999: no citations, so these years are not shown2002–2006: no citations, so these years are not shown2008: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,978 citing papers, 26.8% of this breakdownChina: 2,652 citing papers, 17.8% of this breakdownUnited Kingdom: 734 citing papers, 4.9% of this breakdownItaly: 724 citing papers, 4.9% of this breakdownGermany: 723 citing papers, 4.9% of this breakdownFrance: 525 citing papers, 3.5% of this breakdownCanada: 497 citing papers, 3.3% of this breakdownNetherlands: 421 citing papers, 2.8% of this breakdownJapan: 415 citing papers, 2.8% of this breakdownSpain: 375 citing papers, 2.5% of this breakdownAustralia: 358 citing papers, 2.4% of this breakdownSwitzerland: 305 citing papers, 2.1% of this breakdown
0%26.8%Other 21.3%

Institutions

Fields

  • Medicine65.1%
  • Biochemistry, Genetics and Molecular Biology23.1%
  • Immunology and Microbiology8.7%
  • Engineering0.7%
  • Computer Science0.7%
  • Physics and Astronomy0.6%
  • Other1.1%

Topics

  • Cancer Immunotherapy and Biomarkers13.1%
  • Cancer Genomics and Diagnostics5.1%
  • Immunotherapy and Immune Responses5%
  • Ferroptosis and cancer prognosis3.5%
  • Head and Neck Cancer Studies3.1%
  • CAR-T cell therapy research2.7%
  • Other67.5%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

    Authors: Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, Walter J. Urba, Jennifer S. Sims, F. Stephen Hodi, Salvador Martín‐Algarra, Rajarsi Mandal, William H. Sharfman, Shailender Bhatia, Wen-Jen Hwu, Thomas F. Gajewski, Craig L. Slingluff, Diego Chowell, Sviatoslav M. Kendall, Han Chang, Rachna Shah, Fengshen Kuo, Luc G.T. Morris, John-William Sidhom, Jonathan P. Schneck, Christine E. Horak, Nils Weinhold, Timothy A. Chan - Cell 2017 cited by 2,595

  3. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

    Authors: Claudio Luchini, Frédéric Bibeau, M. Ligtenberg, Naveena Singh, Alessia Nottegar, Tjalling Bosse, Robert E. Miller, Nadeem Riaz, J-Y Douillard, Fabrice André, Aldo Scarpa - Annals of Oncology 2019 cited by 1,054

  4. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

    Authors: Australian Pancreatic Cancer Genome Initiative, Vinod P. Balachandran, Marta Łuksza, Julia N. Zhao, Vladimir Makarov, John A. Moral, Romain Remark, Brian Herbst, Gökçe Aşkan, Umesh Bhanot, Yasin Şenbabaoğlu, Daniel K. Wells, Charles Ian Ormsby Cary, Olivera Grbovic-Huezo, Marc A. Attiyeh, Benjamin D. Medina, Jennifer Zhang, Jennifer K. Loo, Joseph A. Saglimbeni, Mohsen Abu-Akeel, Roberta Zappasodi, Nadeem Riaz, Martin Smoragiewicz, Zakiya Kelley, Olca Baştürk, Mithat Gönen, Arnold J. Levine, Peter J. Allen, Douglas T. Fearon, Miriam Mérad, Sacha Gnjatic, Christine A. Iacobuzio–Donahue, Jedd D. Wolchok, Ronald P. DeMatteo, Timothy A. Chan, Benjamin D. Greenbaum, Taha Merghoub, Steven D. Leach - Nature 2017 cited by 1,229

  5. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

    Authors: Diego Chowell, Luc G.T. Morris, Claud Grigg, Jeffrey K. Weber, Robert Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M. Kendall, David Requena, Nadeem Riaz, Benjamin D. Greenbaum, James M. Carroll, Edward B. Garon, David M. Hyman, Ahmet Zehir, David B. Solit, Michael F. Berger, Ruhong Zhou, Naiyer A. Rizvi, Timothy A. Chan - Science 2017 cited by 1,185

  6. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

    Authors: Jun Li, Mercedes A. Duran Paez, Ninjit Dhanota, Walid K. Chatila, Sarah E. Bettigole, John Kwon, Roshan K. Sriram, Matthew P. Humphries, Manuel Salto‐Tellez, Jacqueline A. James, Matthew G. Hanna, Johannes C. Melms, Sreeram Vallabhaneni, Kevin Litchfield, Ieva Usaite, Dhruva Biswas, Rohan Bareja, Hao Wei Li, M. Laura Martín, Princesca Dorsaint, Julie‐Ann Cavallo, Li Peng, Chantal Pauli, Lee Gottesdiener, Benjamin J. DiPardo, Travis J. Hollmann, Taha Merghoub, Hannah Y. Wen, Jorge S. Reis‐Filho, Nadeem Riaz, Shinsan M. Su, Anusha Kalbasi, Neil Vasan, Simon N. Powell, Jedd D. Wolchok, Olivier Elemento, Charles Swanton, Alexander N. Shoushtari, Eileen E. Parkes, Benjamin Izar, Samuel F. Bakhoum - Cancer Discovery 2020 cited by 280

  7. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

    Authors: Cristina Valero, Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli, Paul K. Paik, George Plitas, Marc Ladanyi, Michael A. Postow, Charlotte E. Ariyan, Alexander N. Shoushtari, Vinod P. Balachandran, A. Ari Hakimi, Aimeé M. Crago, Kara Long Roche, J. Joshua Smith, Ian Ganly, Richard J. Wong, Snehal G. Patel, Jatin P. Shah, Nancy Y. Lee, Nadeem Riaz, Jingming Wang, Ahmet Zehir, Michael F. Berger, Timothy A. Chan, Venkatraman Seshan, Luc G.T. Morris - Nature Communications 2021 cited by 456

  8. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

    Authors: Diego Chowell, Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee, Douglas R. Hoen, Hongyu Shi, Daniel W. Kelly, Neal Patel, Vladimir Makarov, Xiaoxiao Ma, Lynda Vuong, Erich Sabio, Kate Weiss, Fengshen Kuo, Tobias L. Lenz, Robert Samstein, Nadeem Riaz, Prasad S. Adusumilli, Vinod P. Balachandran, George Plitas, A. Ari Hakimi, Omar Abdel‐Wahab, Alexander N. Shoushtari, Michael A. Postow, Robert J. Motzer, Marc Ladanyi, Ahmet Zehir, Michael F. Berger, Mithat Gönen, Luc G.T. Morris, Nils Weinhold, Timothy A. Chan - Nature Biotechnology 2021 cited by 270

  9. The head and neck cancer immune landscape and its immunotherapeutic implications

    Authors: Rajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, Jonathan J. Havel, Martin G. Dalin, Nadeem Riaz, Ken-Wing Lee, Ian Ganly, A. Ari Hakimi, Timothy A. Chan, Luc G.T. Morris - JCI Insight 2016 cited by 790

  10. Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response

    Authors: Rajarsi Mandal, Robert Samstein, Ken-Wing Lee, Jonathan J. Havel, Hao Wang, Chirag Krishna, Erich Sabio, Vladimir Makarov, Fengshen Kuo, Pedro Blecua, Apoorva T. Ramaswamy, Jennifer N. Durham, Bjarne R. Bartlett, Xiaoxiao Ma, Raghvendra M. Srivastava, Sumit Middha, Ahmet Zehir, Jaclyn F. Hechtman, Luc G.T. Morris, Nils Weinhold, Nadeem Riaz, Dung T. Le, Luis A. Díaz, Timothy A. Chan - Science 2019 cited by 581

  11. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

    Authors: C. Jillian Tsai, Jonathan T. Yang, Narek Shaverdian, Juber Patel, Annemarie F. Shepherd, Juliana Eng, David Guttmann, Randy Yeh, Daphna Y. Gelblum, Azadeh Namakydoust, Isabel R. Preeshagul, Shanu Modi, Andrew D. Seidman, Tiffany A. Traina, Pamela Drullinsky, Jessica Flynn, Jessica Flynn, Zhigang Zhang, Erin F. Gillespie, Daniel R. Gomez, Nancy Y. Lee, Michael F. Berger, Mark E. Robson, Mark E Robson, Jorge S Reis-Filho, Charles M. Rudin, Simon N. Powell, Michael F. Berger, Jacqueline Bromberg, Linda Chen, Chau T. Dang, Jeeban P. Das, Pamela Drullinsky, Julianna Eng, Jessica Flynn, Daphna Y. Gelblum, Erin F. Gillespie, Jeffrey Girshman, Daniel R. Gomez, Ayca Gucalp, David Guttmann, Carla Hajj, Daniel S. Higginson, Afsheen N. Iqbal, Atif J. Khan, Quincey LaPlant, Nancy Y. Lee, J.M. Mann, Shanu Modi, Azadeh Namakydoust, Kenneth Ng, Juber Patel, Simon N. Powell, Isabel R. Preeshagul, Isabel Preeshagul, Marsha Reyngold, Marsha Reyngold, Nadeem Riaz, Mark E. Robson, Charles M. Rudin, Rachel Sanford, Andrew D. Seidman, Ronak Shah, Narek Shaverdian, Annemarie F. Shepherd, Jacob Y. Shin, Steven Sugarman, Tiffany A. Traina, C. Jillian Tsai, Abraham J. Wu, Amy Xu, Abraham J Wu, Randy Yeh, Jonathan T Yang, Wanqing Iris Zhi, Zhigang Zhang, Wanqing Iris Zhi - The Lancet 2023 cited by 255

  12. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy

    Authors: Marta Łuksza, Nadeem Riaz, Vladimir Makarov, Vinod P. Balachandran, Matthew D. Hellmann, Alexander Solovyov, Naiyer A. Rizvi, Taha Merghoub, Arnold J. Levine, Timothy A. Chan, Jedd D. Wolchok, Benjamin D. Greenbaum - Nature 2017 cited by 681

  13. Immunogenic neoantigens derived from gene fusions stimulate T cell responses

    Authors: Wei Yang, Ken-Wing Lee, Raghvendra M. Srivastava, Fengshen Kuo, Chirag Krishna, Diego Chowell, Vladimir Makarov, Douglas R. Hoen, Martin G. Dalin, Leonard H. Wexler, Ronald Ghossein, Nora Katabi, Zaineb Nadeem, Marc A. Cohen, Sun Tian, Nicolas Robine, Kanika Arora, Heather Geiger, Phaedra Agius, Nancy Bouvier, Kety Huberman, Katelynd Vanness, Jonathan J. Havel, Jennifer S. Sims, Robert Samstein, Rajarsi Mandal, Justin Tepe, Ian Ganly, Alan L. Ho, Nadeem Riaz, Richard J. Wong, Neerav Shukla, Timothy A. Chan, Luc G.T. Morris - Nature Medicine 2019 cited by 382

  14. Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

    Authors: Sean M. McBride, Eric J. Sherman, C. Jillian Tsai, Shrujal S. Baxi, Jahan Aghalar, Juliana Eng, Wanqing Iris Zhi, Daniel C. McFarland, Loren S. Michel, Robert J. Young, Robert A. Lefkowitz, D. Spielsinger, Zhigang Zhang, Jessica Flynn, Lara Dunn, Alan L. Ho, Nadeem Riaz, David G. Pfister, Nancy Y. Lee - Journal of Clinical Oncology 2020 cited by 394

  15. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

    Authors: Benjamin H. Lok, Eric E. Gardner, Valentina E. Schneeberger, Ai Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A. Teicher, Nadeem Riaz, Simon N. Powell, John T. Poirier, Charles M. Rudin - Clinical Cancer Research 2016 cited by 334

  16. Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

    Authors: Kevin Hadi, Xiaotong Yao, Julie M. Behr, Aditya Deshpande, Charalampos Xanthopoulakis, Huasong Tian, Sarah Kudman, Joel Rosiene, Madison Darmofal, Joseph DeRose, Rick Mortensen, Emily M. Adney, Alon Shaiber, Zoran Gajic, Michael Sigouros, Kenneth Eng, Jeremiah A. Wala, Kazimierz O. Wrzeszczyński, Kanika Arora, Minita Shah, Anne-Katrin Emde, Vanessa Felice, Mayu O. Frank, Robert B. Darnell, Mahmoud Ghandi, Franklin W. Huang, Sally M. Dewhurst, John Maciejowski, Titia de Lange, Jeremy Setton, Nadeem Riaz, Jorge S. Reis‐Filho, Simon N. Powell, David A. Knowles, Ed Reznik, Bud Mishra, Rameen Beroukhim, Michael C. Zody, Nicolas Robine, Kenji Oman, Carissa A. Sanchez, Mary K. Kuhner, Lucian P. Smith, Patricia C. Galipeau, Thomas G. Paulson, Brian J. Reid, Xiaohong Li, David Wilkes, Andrea Sboner, Juan Miguel Mosquera, Olivier Elemento, Marcin Imieliński - Cell 2020 cited by 286

  17. Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

    Authors: Diego Chowell, Chirag Krishna, Federica Pierini, Vladimir Makarov, Naiyer A. Rizvi, Fengshen Kuo, Luc G.T. Morris, Nadeem Riaz, Tobias L. Lenz, Timothy A. Chan - Nature Medicine 2019 cited by 315

  18. Synthetic Lethality in Cancer Therapeutics: The Next Generation

    Authors: Jeremy Setton, Michael Zinda, Nadeem Riaz, Daniel Durocher, Michal Zimmermann, María Koehler, Jorge S. Reis‐Filho, Simon N. Powell - Cancer Discovery 2021 cited by 198

  19. Mitochondrial DNA copy number variation across human cancers

    Authors: Ed Reznik, Martin L. Miller, Yasin Şenbabaoğlu, Nadeem Riaz, Judy Sarungbam, Satish K. Tickoo, Hikmat Al‐Ahmadie, William Lee, Venkatraman Seshan, A. Ari Hakimi, Chris Sander - eLife 2016 cited by 536

  20. The association between tumor mutational burden and prognosis is dependent on treatment context

    Authors: Cristina Valero, Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel, Michael A. Postow, Alexander N. Shoushtari, George Plitas, Vinod P. Balachandran, J. Joshua Smith, Aimeé M. Crago, Kara Long Roche, Daniel W. Kelly, Robert Samstein, Satshil Rana, Ian Ganly, Richard J. Wong, A. Ari Hakimi, Michael F. Berger, Ahmet Zehir, David B. Solit, Marc Ladanyi, Nadeem Riaz, Timothy A. Chan, Venkatraman Seshan, Luc G.T. Morris - Nature Genetics 2021 cited by 260

  21. Tumor Immunity and Immunotherapy for HPV-Related Cancers

    Authors: Achraf A. Shamseddine, Bharat Burman, Nancy Y. Lee, Dmitriy Zamarin, Nadeem Riaz - Cancer Discovery 2021 cited by 193

  22. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

    Authors: Brian O’Sullivan, Shao Hui Huang, Jie Su, Adam S. Garden, Erich M. Sturgis, Kristina R. Dahlstrom, Nancy Y. Lee, Nadeem Riaz, Xin Pei, Shlomo A. Koyfman, David J. Adelstein, Brian B. Burkey, Jeppe Friborg, Claus Andrup Kristensen, Anita Gothelf, Frank Hoebers, Bernd Kremer, Ernst‐Jan M. Speel, Daniel W. Bowles, David Raben, Sana D. Karam, Eugene Yu, Wei Xu - The Lancet Oncology 2016 cited by 741

  23. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

    Authors: Wungki Park, Jiapeng Chen, Joanne F. Chou, Anna M. Varghese, Kenneth H. Yu, Winston Wong, Marinela Capanu, Vinod P. Balachandran, Caitlin A. McIntyre, Imane El Dika, Danny N. Khalil, James J. Harding, Nima Ghalehsari, Zoe McKinnell, Sree B. Chalasani, Vladimir Makarov, Pier Selenica, Xin Pei, Nicolas Lecomte, David P. Kelsen, Ghassan K. Abou‐Alfa, Mark E. Robson, Liying Zhang, Michael F. Berger, Nikolaus Schultz, Timothy A. Chan, Simon N. Powell, Jorge S. Reis‐Filho, Christine A. Iacobuzio–Donahue, Nadeem Riaz, Eileen M. O’Reilly - Clinical Cancer Research 2020 cited by 226

  24. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

    Authors: Robert Samstein, Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov, Fengshen Kuo, Jonathan Chung, Raghvendra M. Srivastava, Tanaya A. Purohit, Douglas R. Hoen, Rajarsi Mandal, Jeremy Setton, Wei Wu, Rachna Shah, Besnik Qeriqi, Qing Chang, Sviatoslav M. Kendall, Lior Z. Braunstein, Britta Weigelt, Pedro Blecua, Luc G.T. Morris, Diana Mandelker, Jorge S. Reis‐Filho, Elisa de Stanchina, Simon N. Powell, Timothy A. Chan, Nadeem Riaz - Nature Cancer 2020 cited by 210